Deals
CEO Shrey Viranna said the Australia and New Zealand combined diagnostic imaging network’s IPO preparations provide “options” to its PE backer.
The Mayne Pharma vs Cosette takeover saga and ensuing legal battles have already reshaped Australian M&A. The latest, precedent-testing lawsuit could do so again.
A week after threatening to walk, SGH boss Ryan Stokes has produced a “best and final” $15 billion bid for the steelmaker, reigniting a takeover standoff that appeared to have frozen.
BlueScope has more than doubled its first-half profit and interim dividend. Its new CEO is calling it an ‘inflection point’.
The annuities giant's circa $300 million acquisition of a stake in Pepper Money has received a frosty response from sections of the market.
The response to Maas Group’s billion dollar asset sale and data centre investment has been brutal, with the stock down 25% on the ASX. But one of its biggest backers says the pivot is the right move.
Humm Group's board infuriated investors after sitting on the buyout bid. But Credit Corp boss Thomas Beregi says he wasn't expecting his confidential offer to be made public.
Nine CEO Matt Stanton has told analysts the media company’s latest acquisition, which the market endorsed, was not “off the cuff” and came together after a year of work.
